-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $310

Benzinga·04/27/2026 15:37:19
Listen to the news
Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $275 to $310.